Alzheimer’s is a global health problem with more than 6 million people living with the disease in the US alone. Tremendous gains have been made in the understanding of the science and basic biology underlying Alzheimer’s and other dementias. These advances are leading to great strides in strategies for prevention, early detection, diagnosis, and therapeutic interventions.
This past June, the FDA approved the first drug for Alzheimer’s in nearly 20 years. But while this treatment may reduce decline, it’s not a cure. Research on better ways to diagnose, treat and to prevent Alzheimer’s continues. The Alzheimer’s Association International Conference (AAIC) is the premier forum to catch up on these exciting changes.
Open to all residents of North Carolina, on August 20, 2021 from 1:00-2:00 p.m. (EST), Dr. Rebecca Edelmayer and Dr. Percy Griffin from the Alzheimer’s Association Medical and Scientific team, will be hosting a live webinar to breakdown some of the exciting developments coming out of AAIC. They will also discuss new developments on the latest Alzheimer’s treatment, Aducanumab.
The Alzheimer’s Association is a global leader in research, mobilizing the field to advance the vision of a world without Alzheimer’s and all other dementia. This event will offer a unique opportunity to learn more about what comes next in the fight to end Alzheimer’s, including exciting research updates and top findings from the Alzheimer’s Association International Conference® 2021 (AAIC®).